1-(3-Chlorophenethyl)-3-(3,3-dimethylcyclopentyl)pyrimidine-2,4,6(1H,3H,5H)-trione

ID: ALA2381014

Chembl Id: CHEMBL2381014

Max Phase: Preclinical

Molecular Formula: C19H23ClN2O3

Molecular Weight: 362.86

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CC1(C)CCC(N2C(=O)CC(=O)N(CCc3cccc(Cl)c3)C2=O)C1

Standard InChI:  InChI=1S/C19H23ClN2O3/c1-19(2)8-6-15(12-19)22-17(24)11-16(23)21(18(22)25)9-7-13-4-3-5-14(20)10-13/h3-5,10,15H,6-9,11-12H2,1-2H3

Standard InChI Key:  PLVFCLKRSMXMLU-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA2381014

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 362.86

Molecular Weight (Monoisotopic): 362.1397

AlogP: 3.64

#Rotatable Bonds: 4

Polar Surface Area: 57.69

Molecular Species: ACID

HBA: 3

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 5.00

CX Basic pKa: ┄

CX LogP: 3.74

CX LogD: 1.40

Aromatic Rings: 1

Heavy Atoms: 25

QED Weighted: 0.77

Np Likeness Score: -0.46

References

1. Kang S, Cooper G, Dunne SF, Luan CH, Surmeier DJ, Silverman RB..  (2013)  Structure-activity relationship of N,N'-disubstituted pyrimidinetriones as Ca(V)1.3 calcium channel-selective antagonists for Parkinson's disease.,  56  (11): [PMID:23651412] [10.1021/jm4005048]

Source

Source(1):

• Scientific Literature